Belle Mead, NJ, United States of America

Joseph C Santoro

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 9.2

ph-index = 4

Forward Citations = 188(Granted Patents)


Company Filing History:


Years Active: 2012-2015

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: Innovations of Joseph C. Santoro: A Pioneer in PCSK9 Antagonists

Introduction

Joseph C. Santoro, a prominent inventor based in Belle Mead, NJ, has made significant contributions to the field of biotechnology with a focus on human proprotein convertase subtilisin-kexin type 9 (PCSK9) antagonists. With a total of 5 patents to his name, his work aims to innovatively address medical conditions associated with PCSK9 activity.

Latest Patents

Joseph C. Santoro's latest patents include advancements in the inhibition of PCSK9 function. Notable patents are 1B20 and 1D05, both disclosing effective antagonists that reveal substantial potential for treating conditions related to PCSK9 activity. These patents detail not only the antagonists themselves but also nucleic acids encoding these antagonists, as well as vectors, host cells, and compositions comprising the antagonists. Furthermore, the methods for creating PCSK9-specific antagonists and utilizing them to inhibit or antagonize PCSK9 function are vital components of Santoro's recent inventions.

Career Highlights

Throughout his career, Joseph has worked with notable organizations such as Merck Sharp & Dohme Corporation and Merck Sharpe & Dohme Corp. His innovative work has positioned him as an important figure within these research institutions, contributing to groundbreaking advancements in the biotechnology sector.

Collaborations

In his journey of innovation, Joseph C. Santoro has collaborated with esteemed colleagues including Ayesha Sitlani and Jon H. Condra. These partnerships have undoubtedly aided in fostering an environment of creativity and advancement in their research endeavors, further enhancing the impact of their collective innovations.

Conclusion

Joseph C. Santoro's contributions to the field of biotechnology through his patented inventions highlight his role as a leading inventor in the development of PCSK9 antagonists. His work not only provides innovative solutions to complex medical issues but also exemplifies the importance of collaboration and dedication in the pursuit of scientific advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…